Ubiquitin System: The Next Class of Drug Targets?
A Complex Role in Cellular Process & Growing Tool Set to Elucidate It
Bispecific Antibodies Close in on Cancer
Plotting Molecular Pincer Movements, Denying Cancer Room to Maneuver
Resolving Nonspecific Binding, Regeneration and Other Problems
Researchers Turn to Cloud Computing as Genomic Sequencing Data Threatens to Overwhelm Traditional IT Systems
For full access to this article login to GEN Select now.
Stem Cell Therapies Make Steady Progress
Preclinical Development of ESC-, iPSC-, CSC-, and CLSC-Derived Products Moves Along Briskly
- Stem cells are many things to many people—a product of an errant procedure, the origin of cancer, a naturally occurring source of unlimited healing potential, a Frankenstein-like creation of virally infected cells, or a political football. CHI’s inaugural “Stem Cells in Drug Discovery and Development,” to be held ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.